dose dense
Showing 1 - 25 of >10,000
Breast Cancer Trial in Shantou (dose-dense nab-paclitaxel followed by EC)
Recruiting
- Breast Cancer
- dose-dense nab-paclitaxel followed by EC
-
Shantou, Guangdong, ChinaShantou Central Hospital
Feb 4, 2023
Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With
Completed
- DLBCL
- Old Age; Debility
-
Homburg, Saarland, GermanySaarland University Medical Center
Nov 20, 2023
Non-Seminomatous Germ Cell Tumor Trial in Villejuif (BEP Protocol, Dose-dense regimen, Early tumor resection or HD-CT)
Not yet recruiting
- Non-Seminomatous Germ Cell Tumor
- BEP Protocol
- +2 more
-
Villejuif, FranceGustave Roussy
Jan 27, 2023
Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))
Recruiting
- Primary Central Nervous System Lymphoma
- Glucarpidase
- Methotrexate (MTX)
-
Paris, FranceHôpital Pitié-Salpêtrière
Oct 24, 2022
Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte
Not yet recruiting
- Early-stage Breast Cancer
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Feb 22, 2023
Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)
Active, not recruiting
- Stage III Breast Cancer AJCC V7
- epirubicin/docetaxel sequential
-
Bergen, NorwayDept of Oncology
Jun 24, 2022
Muscle Invasive Bladder Cancer, Urothelial Carcinoma, Neoadjuvant Chemo Trial in Yangsan (dose dense MVAC with pegylated GCSF)
Recruiting
- Muscle Invasive Bladder Cancer
- +2 more
- dose dense MVAC with pegylated GCSF
-
Yangsan, Gyeongsangnam-do, Korea, Republic ofPusan National University Yangsan Hospital
Feb 2, 2022
Ovarian Cancer Trial in Lexington (Lapatinib and Paclitaxel)
Recruiting
- Ovarian Cancer
- Lapatinib and Paclitaxel
-
Lexington, KentuckyMarkey Cancer Center
Dec 2, 2022
High Grade Serous Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in New York (Carboplatin and Paclitaxel, Nivolumab,
Active, not recruiting
- High Grade Serous Ovarian
- +2 more
- Carboplatin and Paclitaxel
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 13, 2022
Endometrial Cancer Trial in Oklahoma City (Pembrolizumab, Vaginal cuff brachytherapy (VCB), Paclitaxel)
Recruiting
- Endometrial Cancer
- Pembrolizumab
- +3 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 9, 2023
Infiltrating Bladder Urothelial Carcinoma Trial in France (Durvalumab, Tremelimumab, MVAC Protocol)
Recruiting
- Infiltrating Bladder Urothelial Carcinoma
- Durvalumab
- +2 more
-
Paris, Ile De France, France
- +14 more
Apr 21, 2022
Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)
Recruiting
- Immune Thrombocytopenic Purpura
-
Valhalla, New YorkNew York Medical College
Aug 4, 2021
Localized Breast Cancer Trial in Dijon (Dense dose epirubicin-cyclophosphamide chemo and G-CSF (filgrastim, lenograstim), Dense
Not yet recruiting
- Localized Breast Cancer
- Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
- Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)
-
Dijon, Bourgogne, FranceCentre Georges François Leclerc (CGFL)
Mar 24, 2022
Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)
Completed
- Early Stage Breast Cancer
-
Boston, Massachusetts
- +3 more
Apr 11, 2022
Breast Cancer, Triple Negative Breast Cancer, Luminal B Trial in Belgium (Paclitaxel, Epirubicin, Cyclophosphamide)
Active, not recruiting
- Breast Cancer
- +2 more
- Paclitaxel
- +3 more
-
Charleroi, Hainaut, Belgium
- +3 more
Aug 2, 2022
Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))
Completed
- Brain Tumor
- +4 more
- Zotiraciclib (TG02)
- Temozolomide (TMZ)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 3, 2021
HER2-negative Breast Cancer, Neoadjuvant Chemo Trial in Hangzhou (Epirubicin, Cyclophosphamid, Docetaxel)
Recruiting
- HER2-negative Breast Cancer
- Neoadjuvant Chemotherapy
- Epirubicin
- +3 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 9, 2021
Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy,
Active, not recruiting
- Endometrial Cancer
- +2 more
- Vaginal Cuff Brachytherapy
- +2 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Aug 13, 2021
Breast Cancer Trial in Frankfurt (Epirubicin, nab-Paclitaxel, Cyclophosphamide)
Completed
- Breast Cancer
- Epirubicin
- +3 more
-
Frankfurt, Hessen, GermanyKlinikum Frankfurt Höchst
Feb 1, 2021
Glioblastoma Trial in Guangzhou (anlotinib combined with dose-dense temozolomide)
Recruiting
- Glioblastoma
- anlotinib combined with dose-dense temozolomide
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 11, 2020
Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)
Terminated
- Colorectal Cancer Metastatic
- +2 more
-
Bergen, NorwayHaukeland University Hospital
Jan 20, 2021
Tissue Samples From Women Who Underwent Chemotherapy for Lymph
Completed
- Breast Cancer
- cyclophosphamide
- +4 more
-
Saint Louis, MissouriWashington University
Aug 16, 2021
Ovarian Cancer Trial in Wuhan (Pamiparib, Bevacizumab, Tislelizumab)
Not yet recruiting
- Ovarian Cancer
- Pamiparib
- +4 more
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
Oct 6, 2021